Sabra Health Care REIT, Inc. (NASDAQ:SBRA) shares fell -5.72% in last trading session and ended the day at $20.28. SBRA Gross Margin is 98.90% and its has a return on assets of 3.00%. Sabra Health Care REIT, Inc. (NASDAQ:SBRA) quarterly performance is 5.37%.
On 9 March, Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced its outlook for the year ending December 31, 2016. This outlook is exclusive of any net operating income that may be generated from the four Forest Park investments (including the debtor-in-possession loan) or any gains or losses associated with exiting the Forest Park investments that are expected to occur during 2016.
Exact Sciences Corporation (NASDAQ:EXAS) ended the last trading day at $5.93. Company weekly volatility is calculated as 10.63% and price to cash ratio as 1.88. Exact Sciences Corporation (NASDAQ:EXAS) showed a weekly performance of 7.23%.
O Exact Sciences Corporation (NASDAQ:EXAS) said that, on Sunday, March 13, at 5 p.m. CT, Mr. Conroy will join a panel discussion at SXSW 2016 titled “New Cancer Tech: Is Easy Detection a Reality?” The group will review the impact of detecting cancer at its earliest, most treatable stages.
Twitter Inc (NYSE:TWTR) shares moved down -5.95% in last trading session and ended the day at $16.61. TWTR Gross Margin is 67.10% and its has a return on assets of -8.50%. Twitter Inc (NYSE:TWTR) quarterly performance is -33.53%.
On 6 March, Twitter Inc (NYSE:TWTR) has announced its willingness to aid the Crown Prosecution Service to fight against online abuse.
Fibrocell Science, Inc. (NASDAQ:FCSC) shares fell -6.15% in last trading session and ended the day at $2.44. FCSC Gross Margin is -100.00% and its has a return on assets of -49.00%. Fibrocell Science, Inc. (NASDAQ:FCSC) quarterly performance is -52.06%.
Fibrocell Science, Inc. (NASDAQ:FCSC) reported financial results for the fourth quarter and year ended December 31, 2015 For the three months ended December 31, 2015, Fibrocell reported a diluted net loss of $0.40 per share, compared to a diluted net loss of $0.09 per share for the same period in 2014.
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) caters to the Healthcare space. Its weekly performance is -10.93%. On the last day of trading company shares ended up at $16.30. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) distance from 50-day simple moving average (SMA50) is -39.14%.
On 3 March, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) reported a loss of $21.1 million in its fourth quarter. The South San Francisco, California-based company said it had a loss of 75 cents per share. For the year, the company reported profit of $57.2 million, or $2.24 per share.
Leave a Reply